XML 37 R30.htm IDEA: XBRL DOCUMENT v3.25.1
RESTATEMENT OF PREVIOUSLY ISSUED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Tables)
3 Months Ended
Jun. 30, 2024
Accounting Changes and Error Corrections [Abstract]  
SUMMARY OF EFFECT OF RESTATEMENT OF FINANCIAL STATEMENTS

The following tables set forth the restatement of the Company’s condensed consolidated balance sheets as of June 30, 2024 (unaudited), its condensed consolidated statements of operations and condensed consolidated statement of cash flow (unaudited) for the three months ended June 30, 2024.

Unaudited Condensed Consolidated Balance Sheet

 

 

As of June 30, 2024

 

 

 

(Unaudited)

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Equity Issuance
Costs

 

 

Convertible
Notes

 

 

Warrants

 

 

Acquisitions

 

 

Other

 

 

As Restated

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

50,754,570

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

50,754,570

 

Accounts receivable, net

 

 

19,436,712

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

19,436,712

 

Due from related parties

 

 

4,800,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,800,000

 

Inventories

 

 

54,717,709

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

54,717,709

 

Prepaid expenses

 

 

4,244,197

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,244,197

 

Current portion of restricted cash

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Total current assets

 

 

133,953,188

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

133,953,188

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

57,998,933

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

57,998,933

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

1,325,806

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,325,806

 

Patents, net

 

 

4,415,924

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

204,895

 

 

 

4,620,819

 

Other intangible assets, net

 

 

107,982,842

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

107,982,842

 

Goodwill

 

 

90,870,094

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

90,870,094

 

Right of use assets operating leases

 

 

1,825,564

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,825,564

 

Deferred income tax asset

 

 

4,046,430

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,046,430

)

 

 

-

 

TOTAL ASSETS

 

$

402,418,781

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

(3,841,535

)

 

$

398,577,246

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

22,678,651

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

22,678,651

 

Accrued liabilities

 

 

17,141,591

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

34,778

 

 

 

17,176,369

 

Current portion of operating lease liability

 

 

488,887

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

488,887

 

Current portion of construction note payable

 

 

276,616

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

276,616

 

Insurance premium note payable

 

 

1,680,594

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,680,594

 

Total current liabilities

 

 

42,266,339

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

34,778

 

 

 

42,301,117

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

39,852

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

39,852

 

Income tax payable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,609,520

 

 

 

1,609,520

 

Construction note payable, net of unamortized issuance costs

 

 

10,710,081

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,710,081

 

Operating lease liability, net of current portion

 

 

1,426,740

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,426,740

 

Total liabilities

 

 

54,443,012

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,644,298

 

 

 

56,087,310

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred stock

 

 

1,400

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,400

 

Common stock

 

 

118,757

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

118,757

 

Additional paid-in capital

 

 

397,079,854

 

 

 

13,894,620

 

 

 

7,420,492

 

 

 

6,024,240

 

 

 

1,298,336

 

 

 

5,225,000

 

 

 

653,000

 

 

 

431,595,542

 

Accumulated deficit

 

 

(45,455,985

)

 

 

(13,894,620

)

 

 

(7,420,492

)

 

 

(6,024,240

)

 

 

(1,298,336

)

 

 

(5,225,000

)

 

 

(6,138,833

)

 

 

(85,457,506

)

Treasury stock

 

 

(3,768,257

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,768,257

)

Total shareholders’ equity

 

 

347,975,769

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,485,833

)

 

 

342,489,936

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

402,418,781

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

(3,841,535

)

 

$

398,577,246

 

 

Unaudited Condensed Consolidated Statement of Operations

 

 

Three Months Ended June 30, 2024

 

 

 

 

(Unaudited)

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales(1)

 

$

 

13,359,554

 

 

$

 

-

 

 

$

 

-

 

 

$

 

13,359,554

 

 

Marketplace revenue

 

 

 

12,281,991

 

 

 

 

-

 

 

 

 

-

 

 

 

 

12,281,991

 

 

Casing sales

 

 

 

5,312,005

 

 

 

 

-

 

 

 

 

-

 

 

 

 

5,312,005

 

 

Total revenues

 

 

 

30,953,550

 

 

 

 

-

 

 

 

 

-

 

 

 

 

30,953,550

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

21,164,428

 

 

 

 

-

 

 

 

 

11,821

 

 

 

 

21,176,249

 

 

Gross profit

 

 

 

9,789,122

 

 

 

 

-

 

 

 

 

(11,821

)

 

 

 

9,777,301

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

298,613

 

 

 

 

-

 

 

 

 

-

 

 

 

 

298,613

 

 

Corporate general and administrative

 

 

 

11,323,078

 

 

 

 

-

 

 

 

 

-

 

 

 

 

11,323,078

 

 

Employee salaries and related expenses

 

 

 

4,462,101

 

 

 

 

720,034

 

 

 

 

-

 

 

 

 

5,182,135

 

 

Depreciation and amortization expense

 

 

 

3,381,669

 

 

 

 

-

 

 

 

 

-

 

 

 

 

3,381,669

 

 

Total operating expenses

 

 

 

19,465,461

 

 

 

 

720,034

 

 

 

 

-

 

 

 

 

20,185,495

 

 

Income/(loss) from operations

 

 

 

(9,676,339

)

 

 

 

(720,034

)

 

 

 

(11,821

)

 

 

 

(10,408,194

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

252,232

 

 

 

 

-

 

 

 

 

-

 

 

 

 

252,232

 

 

Interest expense

 

 

 

(196,522

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(196,522

)

 

Total other expense

 

 

 

55,710

 

 

 

 

-

 

 

 

 

-

 

 

 

 

55,710

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(9,620,629

)

 

 

 

(720,034

)

 

 

 

(11,821

)

 

 

 

(10,352,484

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(2,559,342

)

 

 

 

-

 

 

 

 

6,966,833

 

 

 

 

4,407,491

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(7,061,287

)

 

 

 

(720,034

)

 

 

 

(6,978,654

)

 

 

 

(14,759,975

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(774,132

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(774,132

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(7,835,419

)

 

$

 

(720,034

)

 

$

 

(6,978,654

)

 

$

 

(15,534,107

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

 

(0.07

)

 

 

 

 

 

 

 

 

 

 $

 

(0.13

)

 

Diluted

 

$

 

(0.07

)

 

 

 

 

 

 

 

 

 

 $

 

(0.13

)

 

 

(1) Included in revenue for the three months ended June 30, 2024 are excise taxes of $1,303,603.

 

Unaudited Condensed Consolidated Statement of Cash Flow

 

 

Three Months Ended June 30, 2024

 

 

 

 

(Unaudited)

 

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

 

As Previously
Reported

 

 

 

Stock Based
Payments

 

 

 

Other

 

 

 

As Restated

 

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(7,061,287

)

 

 

$

(720,034

)

 

 

$

(6,978,654

)

 

 

$

(14,759,975

)

 

Adjustments to reconcile net loss to net cash used in operations:

 

 

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

Depreciation and amortization

 

 

4,692,556

 

 

 

 

-

 

 

 

 

11,821

 

 

 

 

4,704,377

 

 

Debt discount amortization

 

 

20,813

 

 

 

 

-

 

 

 

 

-

 

 

 

 

20,813

 

 

Employee stock awards

 

 

674,949

 

 

 

 

720,034

 

 

 

 

-

 

 

 

 

1,394,983

 

 

Common stock purchase options

 

 

41,055

 

 

 

 

-

 

 

 

 

-

 

 

 

 

41,055

 

 

Contingent consideration payable fair value

 

 

(19,986

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(19,986

)

 

Allowance for doubtful accounts

 

 

87,689

 

 

 

 

-

 

 

 

 

-

 

 

 

 

87,689

 

 

Reduction in right of use asset

 

 

174,529

 

 

 

 

-

 

 

 

 

-

 

 

 

 

174,529

 

 

Valuation allowance

 

 

-

 

 

 

 

-

 

 

 

 

7,182,561

 

 

 

 

7,182,561

 

 

Deferred income taxes

 

 

(2,559,342

)

 

 

 

-

 

 

 

 

(215,728

)

 

 

 

(2,775,070

)

 

Changes in Current Assets and Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

8,696,920

 

 

 

 

-

 

 

 

 

-

 

 

 

 

8,696,920

 

 

Due from related parties

 

 

(4,800,000

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(4,800,000

)

 

Inventories

 

 

(9,154,375

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(9,154,375

)

 

Prepaid expenses

 

 

312,409

 

 

 

 

-

 

 

 

 

-

 

 

 

 

312,409

 

 

Deposits

 

 

(976,528

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(976,528

)

 

Accounts payable

 

 

(477,844

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(477,844

)

 

Accrued liabilities

 

 

9,974,813

 

 

 

 

-

 

 

 

 

-

 

 

 

 

9,974,813

 

 

Operating lease liability

 

 

(173,860

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(173,860

)

 

Net cash used in operating activities

 

 

(547,489

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(547,489

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of equipment

 

 

(1,419,857

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(1,419,857

)

 

Net cash used in investing activities

 

 

(1,419,857

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(1,419,857

)

 

 

 

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

Cash flow from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments on insurance premium note payment

 

 

(721,842

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(721,842

)

 

Payments on construction note payable

 

 

(42,816

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(42,816

)

 

Preferred stock dividends paid

 

 

(638,021

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(638,021

)

 

Repurchase of common shares

 

 

(366,164

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(366,164

)

 

Common stock repurchase plan

 

 

(1,095,682

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(1,095,682

)

 

Net cash used in financing activities

 

 

(2,864,525

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(2,864,525

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

Net decrease in cash

 

 

(4,831,871

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(4,831,871

)

 

Cash, beginning of period

 

 

55,586,441

 

 

 

 

 

 

 

 

 

 

 

 

55,586,441

 

 

Cash, end of period

 

$

50,754,570

 

 

 

$

-

 

 

 

$

-

 

 

 

$

50,754,570

 

 

 

 

 

 

 

 

 

 

 

SUMMARY OF EFFECT OF RESTATEMENT OF ADDITIONAL PAID-IN CAPITAL

The following table presents the Additional Paid-In Capital (“APIC”) as previously reported, restatement adjustments and the APIC as restated for the three months ended June 30, 2024.

 

 

For the three months ended June 30, 2024

 

 

 

 

As Previously Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

 

As Restated

 

 

Employee stock awards

 

$

 

605,838

 

 

$

 

68,750

 

 

$

 

720,034

 

 

 

$

 

1,394,622

 

 

Stock grants

 

$

 

68,750

 

 

$

 

(68,750

)

 

$

 

-

 

 

 

$

 

-